Dr. Celeste T. Williams, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 72
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
MI license 4301078317 -
Internal Medicine Physician
MI license 4301078317
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Henry Ford Health Hospital Detroit, MI
- Cleveland Clinic Martin North Hospital Stuart, FL
- Henry Ford Health West Bloomfield Hospital W Bloomfield, MI
- Ascension Providence Hospital, Southfield and Novi Southfield, MI
Medical groups
- Henry Ford Health System (2,570 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 72
- Services billed
- 244
- Patients’ average age
- 67
| Service | Times | Patients |
|---|---|---|
| Evaluation of lower heart chamber assist device | 47 | 16 |
| Established patient office or other outpatient visit, 40-54 minutes | 39 | 30 |
| New patient office or other outpatient visit, 60-74 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Entresto (sacubitril/valsartan) Other prescribers in Detroit, MI | 115 |
| Carvedilol Other prescribers in Detroit, MI | 95 |
| Bumetanide Other prescribers in Detroit, MI | 80 |
| Vyndamax (tafamidis) | 79 |
| Jardiance (empagliflozin) Other prescribers in Detroit, MI | 74 |
| Eliquis (apixaban) Other prescribers in Detroit, MI | 73 |
| Spironolactone Other prescribers in Detroit, MI | 60 |
| Tacrolimus Other prescribers in Detroit, MI | 57 |
| Atorvastatin Calcium Other prescribers in Detroit, MI | 56 |
| Hydralazine Hcl Other prescribers in Detroit, MI | 55 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 25 payments worth $12,634 in total to this clinician.
| Pfizer Inc. | $12,184 |
|---|---|
| Alnylam Pharmaceuticals Inc. | $147 |
| AstraZeneca Pharmaceuticals LP | $144 |
| E.r. Squibb & Sons, L.l.c. | $49.71 |
| Kestra Medical Technology Services, Inc. | $27.84 |
| Abbott Laboratories | $27.61 |
| Cordis US Corp. | $19.45 |
| Bridgebio Pharma, Inc. | $18.46 |
| Consulting Fee | $8,875 |
|---|---|
| Travel and Lodging | $2,403 |
| Food and Beverage | $804 |
| Compensation for services other than consulting (speaking, faculty) | $552 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Jan 7, 2025 | Consulting Fee | $6,125 |
| Pfizer Inc. May 15, 2025 | Consulting Fee | $2,250 |
| Pfizer Inc. Feb 18, 2025 | Travel and Lodging travel to CHICAGO, IL | $1,215 |
| Pfizer Inc. Feb 18, 2025 | Travel and Lodging VYNDAQEL · CARDIOVASCULAR · travel to CHICAGO, IL · in-kind | $798 |
| Pfizer Inc. Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) | $552 |
| Pfizer Inc. May 15, 2025 | Consulting Fee | $500 |
| Pfizer Inc. May 9, 2025 | Travel and Lodging VYNDAMAX · CARDIOVASCULAR · travel to Irving, TX · in-kind | $205 |
| Pfizer Inc. May 9, 2025 | Travel and Lodging VYNDAMAX · CARDIOVASCULAR · travel to Irving, TX · in-kind | $184 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $55,230 in research payments for these studies, mostly to the institutions running them.
- Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, Inc. · Recruiting · NCT06563895 - OCS Heart Registry (OHP-II)
Transmedics, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.